ibiden - IBIDY
IBIDY
Close Chg Chg %
11.88 0.62 5.22%
Closed Market
12.50
+0.62 (5.22%)
Volume: 100.00
Last Updated:
Feb 6, 2026, 1:04 PM EDT
Company Overview: ibiden - IBIDY
IBIDY Key Data
| Open $12.50 | Day Range 12.50 - 12.50 |
| 52 Week Range 2.91 - 15.59 | Market Cap $12.83B |
| Shares Outstanding 1.12B | Public Float N/A |
| Beta 1.64 | Rev. Per Employee N/A |
| P/E Ratio 47.32 | EPS $0.24 |
| Yield 23.05% | Dividend $0.11 |
| EX-DIVIDEND DATE Sep 30, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 333.59 |
IBIDY Performance
| 1 Week | 13.64% | ||
| 1 Month | 10.93% | ||
| 3 Months | 73.76% | ||
| 1 Year | N/A | ||
| 5 Years | N/A |
IBIDY Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Ibiden - IBIDY
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 3.57B | 3.08B | 2.57B | 2.42B | |
Sales Growth
| +17.06% | -13.66% | -16.76% | -5.55% | |
Cost of Goods Sold (COGS) incl D&A
| 2.50B | 2.14B | 1.86B | 1.69B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 469.96M | 406.12M | 319.52M | 356.31M | |
Depreciation
| - | - | - | - | - |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +11.47% | -14.40% | -13.31% | -8.87% | |
Gross Income
| 1.07B | 941.34M | 709.57M | 731.94M | |
Gross Income Growth
| +32.65% | -11.91% | -24.62% | +3.15% | |
Gross Profit Margin
| +29.93% | +30.54% | +27.66% | +30.20% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 438.37M | 407.14M | 380.17M | 431.00M | |
Research & Development
| 140.02M | 145.29M | 140.08M | 180.07M | |
Other SG&A
| 298.36M | 261.84M | 240.10M | 250.93M | |
SGA Growth
| -0.68% | -7.13% | -6.62% | +13.37% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 19.21M | 8.26M | 30.81M | 127.04M | |
EBIT after Unusual Expense
| 611.06M | 525.94M | 298.58M | 173.91M | |
Non Operating Income/Expense
| (79.97M) | 7.56M | 35.72M | 172.16M | |
Non-Operating Interest Income
| 916.65K | 7.05M | 8.53M | 14.37M | |
Equity in Earnings of Affiliates
| - | 17.80K | 7.38K | 13.85K | |
Interest Expense
| 3.78M | 4.19M | 5.82M | 8.57M | |
Interest Expense Growth
| +55.49% | +10.66% | +39.13% | +47.10% | |
Gross Interest Expense
| 3.78M | 4.19M | 5.82M | 8.57M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 527.31M | 529.31M | 328.47M | 337.49M | |
Pretax Income Growth
| +73.88% | +0.38% | -37.94% | +2.75% | |
Pretax Margin
| +14.77% | +17.17% | +12.80% | +13.93% | |
Income Tax
| 157.41M | 142.39M | 108.61M | 114.14M | |
Income Tax - Current - Domestic
| 169.52M | 175.49M | 106.53M | 140.07M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (12.09M) | (33.10M) | 2.07M | (25.93M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | 17.80K | 7.38K | 13.85K | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 369.89M | 386.92M | 219.85M | 223.35M | |
Minority Interest Expense
| 2.95M | 1.67M | 1.79M | 2.27M | |
Net Income
| 366.95M | 385.25M | 218.05M | 221.08M | |
Net Income Growth
| +51.45% | +4.99% | -43.40% | +1.39% | |
Net Margin Growth
| +10.28% | +12.50% | +8.50% | +9.12% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 366.95M | 385.25M | 218.05M | 221.08M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 366.95M | 385.25M | 218.05M | 221.08M | |
EPS (Basic)
| 0.3285 | 0.1724 | 0.0976 | 0.1979 | |
EPS (Basic) Growth
| +203.04% | -47.52% | -43.39% | +102.77% | |
Basic Shares Outstanding
| 1.12B | 2.23B | 2.23B | 1.12B | |
EPS (Diluted)
| 0.3285 | 0.1724 | 0.0973 | 0.1855 | |
EPS (Diluted) Growth
| +203.04% | -47.52% | -43.56% | +90.65% | |
Diluted Shares Outstanding
| 1.12B | 2.23B | 2.24B | 1.18B | |
EBITDA
| 1.10B | 940.32M | 648.91M | 657.26M | |
EBITDA Growth
| +57.55% | -14.53% | -30.99% | +1.29% | |
EBITDA Margin
| +30.82% | +30.51% | +25.29% | +27.12% |
An error occurred while fetching the data.
SEC Filings for Ibiden - IBIDY
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
An error occurred while fetching the data.